Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: December 1 1969, Volume 29, Issue 12   [Index by Author]       Other Issues: Previous Next  
      Down Articles
      Down Symposium
      Down A Critical Evaluation of Cancer Chemotherapy
      Down Clinical Cancer Chemotherapy Today
      Down Management of Drug-refractory Malignancy and Toxicity
      Down Model Systems
      Down Immunologic Aspects of Cancer Chemotherapy
      Down Design of More Selective Antitumor Agents
      Down General Discussion Session
      Down Basis for Future Approaches
      Down Summation of Symposium
      Down Erratum

[Search ALL Issues]


Table of Contents (PDF) | Editorial Board (PDF) | Front Matter (PDF) | Back Matter (PDF)
To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles:Back

William H. Wolberg
Cancer Res 1969 29: 2137-2144. [Abstract] [PDF]  

J. Emory Morris, J. M. Price, J. J. Lalich, and R. J. Stein
Cancer Res 1969 29: 2145-2156. [Abstract] [PDF]  

Juey Shin Lai Lin, Nancy Huber, and William H. Murphy
Cancer Res 1969 29: 2157-2162. [Abstract] [PDF]  

Juey Shin Lai Lin and William H. Murphy
Cancer Res 1969 29: 2163-2168. [Abstract] [PDF]  

Akira Inagaki, Toru Nakamura, and Gyoichi Wakisaka
Cancer Res 1969 29: 2169-2176. [Abstract] [PDF]  

Alexander Fefer
Cancer Res 1969 29: 2177-2183. [Abstract] [PDF]  

M. B. Shimkin, R. Wieder, M. McDonough, L. Fishbein, and D. Swern
Cancer Res 1969 29: 2184-2190. [Abstract] [PDF]  

James J. Ryan, Alfred S. Ketcham, and Hilda Wexler
Cancer Res 1969 29: 2191-2194. [Abstract] [PDF]  

H. M. Bates, W. Kuenzig, and W. B. Watson
Cancer Res 1969 29: 2195-2205. [Abstract] [PDF]  

W. H. Butler, M. Greenblatt, and W. Lijinsky
Cancer Res 1969 29: 2206-2211. [Abstract] [PDF]  

E. Ertürk, S. M. Cohen, J. M. Price, A. M. Von Esch, A. J. Crovetti, and George T. Bryan
Cancer Res 1969 29: 2212-2218. [Abstract] [PDF]  

E. Ertürk, S. M. Cohen, J. M. Price, and George T. Bryan
Cancer Res 1969 29: 2219-2228. [Abstract] [PDF]  

Lewis R. Mandel, Bruce Hacker, and T. A. Maag
Cancer Res 1969 29: 2229-2231. [Abstract] [PDF]  

Suzanne Q. Chaney, Atsuko Fujimoto, Richard M. Halpern, and Roberts A. Smith
Cancer Res 1969 29: 2232-2236. [Abstract] [PDF]  

Barnet M. Levy, A. Cecil Taylor, Suzanne Hampton, and George W. Thoma
Cancer Res 1969 29: 2237-2248. [Abstract] [PDF]  

Charles L. Vogel, Vincent T. De Vita, Robert P. Lisak, and Marian W. Kies
Cancer Res 1969 29: 2249-2253. [Abstract] [PDF]  

Books Received

Cancer Res 1969 29: 2486 [PDF]  

Special Announcement

Cancer Res 1969 29: 2487 [PDF]  

Announcements

Cancer Res 1969 29: 2487-2488. [PDF]  

Acknowledgment to Reviewers

Cancer Res 1969 29: 2489-2491. [PDF]  

Symposium:Back

A Critical Evaluation of Cancer Chemotherapy: Held at the Cherry Hill Inn Cherry Hill, New Jersey April 9–11, 1969

Cancer Res 1969 29: 2255 [PDF]  

A Critical Evaluation of Cancer Chemotherapy:Back

Program

Cancer Res 1969 29: 2255-2258. [PDF]  

List of Participants

Cancer Res 1969 29: 2259 [PDF]  

Program Committee
H. George Mandel, D. Bernard Amos, Abraham Goldin, Jack W. Milder, and David P. Rall
Cancer Res 1969 29: 2260 [PDF]  

Introduction
H. George Mandel
Cancer Res 1969 29: 2261 [PDF]  

Clinical Cancer Chemotherapy Today:Back

Success and Failure in Present Chemotherapy and the Implications of Asparaginase
Joseph H. Burchenal
Cancer Res 1969 29: 2262-2269. [PDF]  

Formal Discussion of J. H. Burchenal's Paper, "Success and Failure in Present Chemotherapy and the Implications of Asparaginase"
James F. Holland
Cancer Res 1969 29: 2270-2271. [PDF]  

Evidence That Drugs in Multiple Combinations Have Materially Advanced the Treatment of Human Malignancies
Edward S. Henderson and Richard J. Samaha
Cancer Res 1969 29: 2272-2280. [PDF]  

Formal Discussion: Cautionary Considerations of Combination Chemotherapy in the Treatment of Human Malignancies
Charles W. Young
Cancer Res 1969 29: 2281-2283. [PDF]  

Summary of Informal Discussion on Clinical Cancer Chemotherapy Today
C. Gordon Zubrod
Cancer Res 1969 29: 2284 [PDF]  

Abraham Goldin
Cancer Res 1969 29: 2285-2291. [Abstract] [PDF]  

Alan C. Sartorelli
Cancer Res 1969 29: 2292-2299. [Abstract] [PDF]  

The Mechanism of Induction of Complete Remission in Acute Myeloblastic Leukemia in Man
J. S. Hart, S. Shirakawa, J. Trujillo, and E. Frei, III
Cancer Res 1969 29: 2300-2307. [PDF]  

Management of Drug-refractory Malignancy and Toxicity:Back

An Empirical Cellular Approach to the Improvement of Cancer Chemotherapy
W. R. Bruce and H. Lin
Cancer Res 1969 29: 2308-2310. [PDF]  

Formal Discussion of W. R. Bruce and H. Lin's Paper, "An Empirical Cellular Approach to the Improvement of Cancer Chemotherapy"
C. Gordon Zubrod
Cancer Res 1969 29: 2311 [PDF]  

Formal Discussion of W. R. Bruce and H. Lin's Paper, "An Empirical Cellular Approach to the Improvement of Cancer Chemotherapy"
Karl Karrer
Cancer Res 1969 29: 2312-2313. [PDF]  

Effective Means of Reducing Toxicity without Concomitant Sacrifice of Efficacy of Carcinostatic Therapy
G. A. LePage and Takeo Kaneko
Cancer Res 1969 29: 2314-2318. [PDF]  

Seymour Perry
Cancer Res 1969 29: 2319-2325. [Abstract] [PDF]  

Summary of Informal Discussion on the Management of Drug-refractory Malignancy and Toxicity
Daniel E. Bergsagel
Cancer Res 1969 29: 2326-2328. [PDF]  

Model Systems:Back

Improvement of the Model Systems
Howard E. Skipper
Cancer Res 1969 29: 2329-2333. [PDF]  

Daniel E. Bergsagel and Chan H. Park
Cancer Res 1969 29: 2334-2338. [Abstract] [PDF]  

Summary of Informal Discussion on the Model Systems
S. Garattini
Cancer Res 1969 29: 2339-2344. [PDF]  

Immunologic Aspects of Cancer Chemotherapy:Back

Modification of Tumor Regression by Immunologic Means
E. Mihich
Cancer Res 1969 29: 2345-2350. [PDF]  

Edmund Klein
Cancer Res 1969 29: 2351-2362. [Abstract] [PDF]  

John F. Burke
Cancer Res 1969 29: 2363-2367. [Abstract] [PDF]  

Immunologic Parameters of Host-Tumor Relationships: Spontaneous Mammary Neoplasia of the Inbred Mouse as a Model
David W. Weiss
Cancer Res 1969 29: 2368-2373. [PDF]  

Marc A. Lappé and Richmond T. Prehn
Cancer Res 1969 29: 2374-2378. [Abstract] [PDF]  

Formal Discussion of Marc A. Lappé and R. T. Prehn's Paper, "Immunologic Surveillance at the Macroscopic Level: Nonselective Elimination of Premalignant Skin Papillomas"
D. Bernard Amos
Cancer Res 1969 29: 2379-2380. [PDF]  

Summary of Informal Discussion on the Immunologic Aspects of Cancer Chemotherapy
D. Bernard Amos
Cancer Res 1969 29: 2381-2383. [PDF]  

Design of More Selective Antitumor Agents:Back

Frank M. Schabel, Jr.
Cancer Res 1969 29: 2384-2389. [Abstract] [PDF]  

Mortimer L. Mendelsohn
Cancer Res 1969 29: 2390-2393. [Abstract] [PDF]  

The G1 -> S Conversion: A Target for Cancer Chemotherapy
Gerald C. Mueller
Cancer Res 1969 29: 2394-2397. [PDF]  

Alternative de Novo and "Salvage" Pathways to Thymidine Triphosphate Synthesis: Possible Implications for Cancer Chemotherapy
Thomas W. Sneider and Van R. Potter
Cancer Res 1969 29: 2398-2403. [PDF]  

J. Frank Henderson
Cancer Res 1969 29: 2404-2406. [Abstract] [PDF]  

Summary of Informal Discussion on the Design of More Selective Antitumor Agents
David P. Rall
Cancer Res 1969 29: 2407 [PDF]  

Prospects in Endocrinology for Chemotherapy
Mortimer B. Lipsett
Cancer Res 1969 29: 2408-2411. [PDF]  

Thomas C. Hall
Cancer Res 1969 29: 2412-2416. [Abstract] [PDF]  

J. R. Bertino and P. F. Nixon
Cancer Res 1969 29: 2417-2421. [Abstract] [PDF]  

Charles A. Nichol
Cancer Res 1969 29: 2422-2426. [Abstract] [PDF]  

General Discussion Session:Back

Summary of the General Discussion Session
Abraham Goldin
Cancer Res 1969 29: 2427-2434. [PDF]  

Basis for Future Approaches:Back

The Need for Additional Alkylating Agents and Antimetabolites
Charles Heidelberger
Cancer Res 1969 29: 2435-2442. [PDF]  

T. A. Connors
Cancer Res 1969 29: 2443-2447. [Abstract] [PDF]  

Gertrude B. Elion
Cancer Res 1969 29: 2448-2453. [Abstract] [PDF]  

Utilization of Segments of Nuclear Macromolecules in Cancer Chemotherapy
Harris Busch and Wesley C. Starbuck
Cancer Res 1969 29: 2454-2456. [PDF]  

Joseph Leighton
Cancer Res 1969 29: 2457-2465. [Abstract] [PDF]  

Robert E. Handschumacher
Cancer Res 1969 29: 2466-2468. [Abstract] [PDF]  

Charles A. Nichol
Cancer Res 1969 29: 2469-2470. [Abstract] [PDF]  

David P. Rall
Cancer Res 1969 29: 2471-2474. [Abstract] [PDF]  

Summary of Informal Discussion on the Basis for Future Approaches to Cancer Chemotherapy
H. George Mandel
Cancer Res 1969 29: 2475-2477. [PDF]  

Summation of Symposium:Back

The Present Status of Cancer Chemotherapy—A Summary of Papers Delivered at the Cherry Hill Conference on "A Critical Evaluation of Cancer Chemotherapy"
H. George Mandel and David P. Rall
Cancer Res 1969 29: 2478-2485. [PDF]  

Erratum:Back

Formation of Antibodies against Salmonella Lipopolysaccharides during a Latent Infection by Friend Murine Leukemia Virus

Cancer Res 1969 29: 2488 [PDF]  

Selective Effects of a New Metal-complexed Azo Dye on Proteins of the Reed-Sternberg Cell

Cancer Res 1969 29: 2488 [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2007 by the American Association for Cancer Research.